Two-person startup Love Lifesciences just landed a $25,000 grant from the Kansas Department of Commerce’s KITE Proof of Concept program. The innovation and commercialization incentive from the state is designed to fill the funding gap between the Federal SBIR research grant and commercial seed funding.
CEO Nick Love and CTO Bradley Hopper, Love Lifesciences
“This grant is going to go towards helping us with the development of our manufacturing processes, one of the major hurdles to actually achieving FDA clearance for our device,” CEO Nick Love told the 4thEst8. “We have to go in and actually produce out all those manufacturing processes to produce devices so that we can test on those specific devices.”
The startup is developing a series of safety injection devices to prevent needlestick and dosing error, as well as an improved injection experience for those self administering medications. The road to FDA approval to sell a medical device is often long, but Love and co-founder CTO Bradley Hopper hope their startup can clear the major hurdles in the next year.
The company LinkedIn page says it launched in October of 2020 but corporate filings show it was then registered as a corporation in May 2021.
Links:
